| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Faculty List/Faculty Disclosure
|
|
|
2007
|
100 |
11S1 |
p. v-vii
nvt p.
|
artikel
|
| 2 |
High-Density Lipoprotein Metabolism: Potential Therapeutic Targets
|
Davidson, Michael H.
|
|
2007
|
100 |
11S1 |
p. S32-S40
9 p.
|
artikel
|
| 3 |
High-Density Lipoprotein Mimetics: Focus on Synthetic High-Density Lipoprotein
|
Shah, Prediman K.
|
|
2007
|
100 |
11S1 |
p. S62-S67
6 p.
|
artikel
|
| 4 |
Increasing High-Density Lipoprotein Cholesterol, Inhibition of Cholesteryl Ester Transfer Protein, and Heart Disease Risk Reduction
|
Schaefer, Ernst J.
|
|
2007
|
100 |
11S1 |
p. S25-S31
7 p.
|
artikel
|
| 5 |
Introduction
|
Davidson, Michael H.
|
|
2007
|
100 |
11S1 |
p. S1-S2
2 p.
|
artikel
|
| 6 |
Lipids, Lipoproteins, and Peroxisome Proliferator Activated Receptor–δ
|
Sprecher, Dennis L.
|
|
2007
|
100 |
11S1 |
p. S20-S24
5 p.
|
artikel
|
| 7 |
Liver X Receptor and Farnesoid X Receptor as Therapeutic Targets
|
Rader, Daniel J.
|
|
2007
|
100 |
11S1 |
p. S15-S19
5 p.
|
artikel
|
| 8 |
Nicotinic Acid (Niacin) Receptor Agonists: Will They Be Useful Therapeutic Agents?
|
Kamanna, Vaijinath S.
|
|
2007
|
100 |
11S1 |
p. S53-S61
9 p.
|
artikel
|
| 9 |
Novel Peroxisome Proliferator Activated Receptor–α Agonists
|
Fruchart, Jean-Charles
|
|
2007
|
100 |
11S1 |
p. S41-S46
6 p.
|
artikel
|
| 10 |
Refocusing On Use of Cholesteryl Ester Transfer Protein Inhibitors
|
Kastelein, John J.P.
|
|
2007
|
100 |
11S1 |
p. S47-S52
6 p.
|
artikel
|
| 11 |
Regulatory Considerations in the Development of High-Density Lipoprotein Therapies
|
Orloff, David G.
|
|
2007
|
100 |
11S1 |
p. S10-S14
5 p.
|
artikel
|
| 12 |
Targeting the Anti-Inflammatory Effects of High-Density Lipoprotein
|
Ansell, Benjamin J.
|
|
2007
|
100 |
11S1 |
p. S3-S9
7 p.
|
artikel
|
| 13 |
Title page
|
|
|
2007
|
100 |
11S1 |
p. i-
1 p.
|
artikel
|
Tijdschrift beschrijving